December 15, 2022 December 15, 2022Categories News StoriesStudy E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)
December 14, 2022 December 14, 2022Categories News StoriesBlinatumomab further improves survival among patients with B-ALL and a good prognosis (study E1910)
December 13, 2022 December 13, 2022Categories News StoriesImmunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL
December 13, 2022 December 13, 2022Categories News StoriesBlinatumomab regimen may lead to ‘diminishing use of transplant’ for B-ALL subgroup (study E1910)
December 13, 2022 December 13, 2022Categories Press ReleasesPress Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)
October 20, 2022 October 20, 2022Categories Announcements Press ReleasesPress Release: ECOG-ACRIN taps the University of Pennsylvania’s Selina Luger to lead its Leukemia Committee
October 13, 2022 October 13, 2022Categories Announcements News StoriesThe September/October 2022 News from ECOG-ACRIN blog is now available